NFKB1 and amyotrophic lateral sclerosis: In addition, clemastine in the early phase prompts immune cells to acquire an anti-inflammatory phenotype during the late phase of the disease, as shown by the decreased expression of the proinflammatory factor NF-kB, well known to contribute to immune-mediated motoneuron death in ALS [31].